|Podcasts|June 30, 2022
Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1
In part 1 of this 2-part podcast, a panel of experts discusses treatment goals in patients with interstitial lung disease (ILD) and reviews of treatment paradigms and standard of care therapies
Advertisement
Today we are bringing you part 1 of a 2-part sponsored podcast series discussing treatment goals in insterstitial lung disease (ILD). The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.
The topics of conversation for today’s podcast include treatment goals in patients with ILD and a review of treatment paradigms and standard of care therapies.
Listen above or through one of these podcast services:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
3
Contributor: Artificial Intelligence Grows Across Health Care, Led by Administrative Processes
4
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
5